KR850001291A - 폴리에테르 항생물질 x-14934a의 제조방법 - Google Patents

폴리에테르 항생물질 x-14934a의 제조방법 Download PDF

Info

Publication number
KR850001291A
KR850001291A KR1019840004421A KR840004421A KR850001291A KR 850001291 A KR850001291 A KR 850001291A KR 1019840004421 A KR1019840004421 A KR 1019840004421A KR 840004421 A KR840004421 A KR 840004421A KR 850001291 A KR850001291 A KR 850001291A
Authority
KR
South Korea
Prior art keywords
formula
compound
preparing polyether
polyether antibiotic
image
Prior art date
Application number
KR1019840004421A
Other languages
English (en)
Other versions
KR910005629B1 (ko
Inventor
웨슬리 존 (외 1)
Original Assignee
진-작크스오게이,메인라드 쉬미드
에프호프만-라 롯슈 앤드 캄파니 아크티엔 게쩔샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 진-작크스오게이,메인라드 쉬미드, 에프호프만-라 롯슈 앤드 캄파니 아크티엔 게쩔샤프트 filed Critical 진-작크스오게이,메인라드 쉬미드
Publication of KR850001291A publication Critical patent/KR850001291A/ko
Application granted granted Critical
Publication of KR910005629B1 publication Critical patent/KR910005629B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/46Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
    • C12P19/54Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin the cyclohexyl radical being bound directly to a nitrogen atom of two or more radicals, e.g. streptomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/445The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/55Streptomyces hygroscopicus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Fodder In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

폴리에테르 항생물질 X-14934A의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 호기성 액침 배양조건하에 질소영향물을 함유하는 탄수화물 수용액중에서 스트렙토마이세스 X-14934 균주를 배양시킨 후 상기 용액으로부터 일반식(I)의 화합물을 분리시키고, 경우에 따라 일반식(I)의 화합물의 염을 형성시킴을 특징으로 하는 일반식(I) 화합물의 제조방법.
  2. 제1항에 있어서 일반식(I) 화합물의 나트륨염을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004421A 1983-07-28 1984-07-25 폴리에테르 항생물질 x-14934a의 제조방법 KR910005629B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/518,233 US4510317A (en) 1983-07-28 1983-07-28 Antibiotic X-14934A
US518233 1983-07-28

Publications (2)

Publication Number Publication Date
KR850001291A true KR850001291A (ko) 1985-03-18
KR910005629B1 KR910005629B1 (ko) 1991-08-01

Family

ID=24063126

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004421A KR910005629B1 (ko) 1983-07-28 1984-07-25 폴리에테르 항생물질 x-14934a의 제조방법

Country Status (21)

Country Link
US (1) US4510317A (ko)
EP (1) EP0133971B1 (ko)
JP (1) JPS6051198A (ko)
KR (1) KR910005629B1 (ko)
AT (1) ATE33390T1 (ko)
AU (1) AU575574B2 (ko)
CA (1) CA1253097A (ko)
DE (1) DE3470313D1 (ko)
DK (1) DK159452C (ko)
ES (1) ES534644A0 (ko)
FI (1) FI76836C (ko)
GR (1) GR82437B (ko)
HU (1) HU193017B (ko)
IE (1) IE57274B1 (ko)
IL (1) IL72517A (ko)
MC (1) MC1615A1 (ko)
NO (1) NO158881C (ko)
NZ (1) NZ209022A (ko)
PH (1) PH20120A (ko)
PT (1) PT78991B (ko)
ZA (1) ZA845601B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707493A (en) * 1983-02-15 1987-11-17 Pfizer Inc. 19-epi-dianemycin as an anticoccidial and antibacterial agent
US4591559A (en) * 1983-07-28 1986-05-27 Hoffmann-La Roche Inc. Antibiotic X-14934A and a method for its preparation
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0209971B1 (en) * 1985-05-28 1991-03-06 Eli Lilly And Company Polyether antibiotic and process for its production
US5888788A (en) * 1994-05-18 1999-03-30 Union Nationale Des Groupements De Distillateurs D'alcool (Ungda) Use of ionophoretic polyether antibiotics for controlling bacterial growth in alcoholic fermentation
TW393413B (en) * 1996-01-19 2000-06-11 Shimano Kk Clipless bicycle pedal with large shoe-contacting area
EP2825178A4 (en) * 2012-03-16 2015-10-14 Univ Georgia GLYCOMIMETIKA FOR INHIBITING PATHOGEN HOST INTERACTIONS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953474A (en) * 1974-11-15 1976-04-27 Eli Lilly And Company Antibiotic A204I derivatives
GB2024806B (en) * 1978-03-16 1982-05-06 Taisho Pharmaceutical Co Ltd Onomycin derivatives
JPS5592387A (en) * 1978-12-29 1980-07-12 Taisho Pharmaceut Co Ltd Antibiotic substance tm-531
US4431665A (en) * 1979-08-13 1984-02-14 Syntex (U.S.A.) Inc. Acylated laidlomycin derivatives
FR2463144A1 (fr) * 1979-08-13 1981-02-20 Syntex Inc Nouveaux diesters de laidlomycine, leur procede de production, compositions a usage veterinaire les contenant et leur utilisation pour accroitre le rendement d'assimilation des aliments chez un ruminant
US4359583A (en) * 1980-09-16 1982-11-16 Taisho Pharmaceutical Co., Ltd. Antibiotics TM-531 B and TM-531 C
US4361649A (en) * 1981-07-20 1982-11-30 Pfizer Inc. Polycyclic ether antibiotic
GB2113671A (en) * 1982-01-19 1983-08-10 Pfizer Ltd Polycyclic ether antibiotics
GT198400008A (es) * 1983-02-15 1985-07-12 19-epi-dianemicina y procedimiento para el mismo
US4552843A (en) * 1984-02-17 1985-11-12 Pfizer Inc. Process for producing an acidic polycyclic ether antibiotic by cultivation of a novel strain of Streptomyces endus subspecies aureus

Also Published As

Publication number Publication date
ES8600640A1 (es) 1985-10-16
PT78991B (en) 1986-10-23
DK366084A (da) 1985-01-29
IE57274B1 (en) 1992-07-01
NO843054L (no) 1985-01-29
HUT36178A (en) 1985-08-28
EP0133971B1 (de) 1988-04-06
GR82437B (ko) 1984-12-13
HU193017B (en) 1987-08-28
NO158881C (no) 1988-11-09
PH20120A (en) 1986-10-02
ZA845601B (en) 1985-03-27
DK159452B (da) 1990-10-15
NO158881B (no) 1988-08-01
AU575574B2 (en) 1988-08-04
IL72517A (en) 1988-03-31
DE3470313D1 (en) 1988-05-11
US4510317A (en) 1985-04-09
FI76836B (fi) 1988-08-31
AU3124684A (en) 1985-01-31
KR910005629B1 (ko) 1991-08-01
NZ209022A (en) 1987-08-31
MC1615A1 (fr) 1985-07-18
PT78991A (en) 1984-08-01
CA1253097A (en) 1989-04-25
FI843009A0 (fi) 1984-07-27
FI843009A (fi) 1985-01-29
DK159452C (da) 1991-03-18
IE841949L (en) 1985-01-28
EP0133971A1 (de) 1985-03-13
IL72517A0 (en) 1984-11-30
ATE33390T1 (de) 1988-04-15
JPS6051198A (ja) 1985-03-22
ES534644A0 (es) 1985-10-16
DK366084D0 (da) 1984-07-26
FI76836C (fi) 1988-12-12

Similar Documents

Publication Publication Date Title
ES8606262A1 (es) Procedimiento para preparar derivados de pleuromutilina
KR850006391A (ko) 벤조치아졸 및 벤조치오펜 유도체의 제조방법
KR860001110A (ko) 항균제 ⅱ의 제법
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
KR850001291A (ko) 폴리에테르 항생물질 x-14934a의 제조방법
KR890012991A (ko) 광학활성을 갖는 4-옥소-1-벤조피란-2-카르복시산 유도체 및 중간체의 제법
ES8104213A1 (es) Procedimiento para la preparacion de acido 4,4'dinitro es- tilben-2,2'-disulfonico y sus sales
ZA794155B (en) New aminoglycosides derived from desoxystreptamine,and their salts,their preparation process,their application as medicaments and the pharmaceutical compounds containing them
ES8302093A1 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
KR920019742A (ko) L-프롤린 유도체의 제조방법
KR850003730A (ko) 항생물질 x-14889 a, b, c 및 d의 제조방법
KR840008367A (ko) 악타플라닌 항생물질의 제조방법
ES8400121A1 (es) Procedimiento para la obtencion de derivados de 11-amino-papulacandina a y b.
SE7708939L (sv) Antibiotika
KR850006873A (ko) 산성 폴리사이클릭 에테르 항생물질의 제조방법
KR920014774A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
ES460266A1 (es) Procedimiento para la produccion del antibiotico bl 580 del-ta.
KR890006571A (ko) 안트라사이클린(anthracycline) 유도체, 이의 제조방법 및 이의 약제로서의 용도
SE8106254L (sv) Forfarande for framstellning av alkyletrar
KR860004008A (ko) 부타놀유도체의 제법
KR850000453A (ko) 세팔로스포린산과 그 유도체의 제조방법
KR850006933A (ko) 설파모일-치환된 펜에틸아민 유도체의 제조방법
KR870010062A (ko) 세파로스포린 유도체의 제조방법
KR830005192A (ko) 2,4-디아미노-5-설파모일 벤젠 설폰산의 제조방법
KR850005839A (ko) 에르고트 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee